Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Cost of nitroglycerin pills?Delgocitinib patent wo?Cost of atropine eye drops?Flexeril cost without insurance?Why is anoro ellipta so expensive?
See the DrugPatentWatch profile for Yupelri
The available package sizes for Yupelri (a nebulized bronchodilator used for COPD) are: * 100 mL vial [1] * 200 mL vial [1]
Yupelri is administered via nebulization, meaning it is turned into a fine mist that can be inhaled directly into the lungs. This method of delivery allows the medication to reach the airways efficiently.
Yupelri is developed and marketed by Mylan Pharmaceuticals, a subsidiary of Viatris Inc. [1]
Yupelri is indicated for the treatment of chronic obstructive pulmonary disease (COPD) in adults [1]. It works by relaxing the muscles in the airways, which helps to improve airflow and reduce symptoms such as shortness of breath.
Information regarding Yupelri's patent status, regulatory approvals, and clinical trial data can be found through resources like DrugPatentWatch.com [2]. This site tracks drug patents, exclusivity periods, and other intellectual property relevant to pharmaceutical products.
Other Questions About Yupelri :